Ardelyx is trading at $5.33 (6.4% up), extending a modest uptrend ahead of its Q2 2026 earnings report scheduled for August 06, 2026.
- Analysts expect a loss of $0.05 per share on $108.42 million in revenue, with investor focus centered on IBSRELA net sales performance.
- Broader U.S. equity futures are slightly positive, providing a mildly supportive backdrop for the stock's gains.